AI Software Stocks Decline as NET Falls More Than 12%, SNOW Over 10%, NOW Over 7%, SAP Nearly 4%, and PLTR Drops Around 7.5% Due to AI Competition Worries.
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 09 2026
0mins
Should l Buy PLTR?
Source: moomoo
Stock Performance: Major software stocks have experienced significant declines, with NET dropping over 12%, SNOW over 10%, NOW over 7%, and SAP nearly 4%.
PLTR Decline: Palantir Technologies (PLTR) saw a decrease of about 7.5% amid growing concerns over competition in the AI sector.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PLTR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PLTR
Wall Street analysts forecast PLTR stock price to rise
17 Analyst Rating
5 Buy
10 Hold
2 Sell
Hold
Current: 137.050
Low
50.00
Averages
192.88
High
255.00
Current: 137.050
Low
50.00
Averages
192.88
High
255.00
About PLTR
Palantir Technologies Inc. is engaged in building software to assist in counterterrorism investigations and operations. The Company has built four principal software platforms, including Palantir Gotham (Gotham), Palantir Foundry (Foundry), Palantir Apollo (Apollo), and Palantir Artificial Intelligence Platform (AIP). Apollo is a cloud-agnostic, single control layer that coordinates ongoing delivery of new features, security updates, and platform configurations, helping to ensure the continuous operation of critical systems. Gotham enables users to identify patterns hidden deep within datasets, ranging from signals intelligence sources to reports from confidential informants. Foundry transforms the ways organizations operate by creating a central operating system for their data. AIP enables responsible artificial intelligence (AI)-advantage across the enterprise by using primary, core components built to effectively activate large language models and other AI within any organization.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Cathie Wood's Top AI Stock Pick: Palantir Technologies
- Positive Investment Outlook: Cathie Wood holds a $574 million stake in Palantir Technologies, reflecting strong confidence in the company amid rising geopolitical conflicts and military budgets, positioning it as a full-stack AI platform for modern warfare.
- Integrated Technology Advantage: Palantir's Foundry, Gotham, and Apollo systems are tightly integrated, providing a comprehensive solution from data collection to real-time decision-making, making it a one-stop shop for government defense needs and enhancing operational efficiency.
- Enhanced Target Identification: With AI integration, Palantir's target identification capacity has surged from 100 targets per day to 5,000, with future iterations expected to reach 1,000 targets per hour, significantly reducing decision cycles and improving military responsiveness.
- Outstanding Market Performance: Despite being the biggest detractor in GMO's portfolio, Palantir's stock surged 135% over the past year, indicating market recognition of its growth potential, even as its price-to-sales ratio exceeds 100, continuing to attract investor interest.
See More
NHS Grants Palantir Unlimited Access to Patient Data
- Access Permission Change: The UK's National Health Service (NHS) has decided to grant staff from companies including Palantir 'unlimited access' to identifiable patient data to support the development of its flagship data platform, raising significant public concern over data privacy.
- Large Contract Value: Palantir secured a £330 million ($448.4 million) contract in 2023 to develop the National Data Integration Tenant (NDIT) for the NHS, aimed at integrating disparate NHS datasets into a single system to enhance data management efficiency.
- External Access Management: NHS has agreed to create an 'admin' role allowing non-staff unlimited access to the NDIT and identifiable patient data, although an internal briefing note recommends capping external admin access and subjecting such permissions to regular review to ensure data security.
- Public Scrutiny and Review: Palantir's data access has drawn considerable public scrutiny due to its work with U.S. government defense agencies, with the briefing note suggesting that external access should be time-limited and regularly reviewed to address concerns over patient data access.
See More
Palantir Reports Strong Revenue and Profit Growth
- Significant Revenue Growth: Palantir's stock price on the afternoon of May 7, 2026, indicates strong revenue growth, suggesting the company's performance continues to improve, which is expected to further boost investor confidence.
- Profit Increase: The company reports profit growth, reflecting the effectiveness of its business model and strong market demand, which may attract more institutional investors' attention.
- Positive Market Reaction: Following the video release, Palantir's stock price rose by 0.55%, demonstrating investor optimism regarding the company's future development and enhancing its competitiveness in the tech industry.
- Optimistic Strategic Outlook: With simultaneous revenue and profit growth, Palantir is poised to continue expanding its market share in the future, further solidifying its leadership position in the data analytics sector.
See More
Karp Critiques AI Models as Business Threat
- Executive Warning: CEO Alex Karp's criticism of internal 'slop' indicates concerns about operational efficiency, suggesting that the company risks losing its competitive edge if not addressed.
- Investor Concerns: Investors are reacting to Karp's remarks with apprehension, believing that failure to effectively tackle the challenges posed by AI models could impact market share and long-term profitability.
- Employee Anxiety: Some employees express unease about the company's future direction, fearing that the rise of AI models may lead to layoffs or business restructuring, thereby affecting job security.
- Need for Strategic Adjustment: Karp's critique underscores the necessity for the company to make strategic adjustments to navigate the rapidly changing technological landscape, ensuring competitiveness in the AI sector and safeguarding core business operations.
See More
Palantir Reports 85% Revenue Surge in Q1, Raises Guidance
- Significant Revenue Growth: Palantir's Q1 total revenue reached $1.633 billion, marking an 85% year-over-year increase, with U.S. revenue soaring 104% to $1.282 billion, indicating strong performance amid accelerating AI demand.
- Government and Commercial Revenue Surge: U.S. government revenue accounted for $687 million, an 84% increase, while commercial revenue rose 133% to $595 million, demonstrating the company's expanding market penetration across various sectors.
- Upgraded Annual Revenue Guidance: Following the robust Q1 results, Palantir raised its 2023 revenue guidance to between $7.650 billion and $7.662 billion, reflecting the company's confidence in future growth prospects.
- Analyst Price Target Increases: Citi and Rosenblatt both raised their price targets to $225, while Bank of America set a target of $255, indicating a positive market outlook for Palantir's future performance.
See More
Palantir Reports Exceptional Q1 Performance Amidst Growth Concerns
- Accelerating Growth: Palantir's Q1 revenue surged 85% year-over-year, with U.S. commercial growth reaching an impressive 133%, indicating strong demand for its data analytics platform, even as its stock remains 29% below its all-time high.
- High Profit Margins: The company reported an operating margin of 46% in Q1, up from 27% a year ago, showcasing its success in efficient operations and client acquisition, thereby enhancing its competitive position in the market.
- Market Concerns and Valuation Pressure: Despite exceeding Wall Street expectations, Palantir's P/E ratio stands at 75 and its price-to-sales ratio at 70, suggesting that much of the growth is already priced in, which may lead to downward pressure on the stock.
- Future Outlook and Growth Potential: CEO Karp anticipates revenue doubling by 2027, and if the compound annual growth rate reaches 50%, revenue could rise from $5 billion to approximately $40 billion, indicating potential value for patient investors despite necessary price adjustments.
See More
Cathie Wood's Top AI Stock Pick: Palantir Technologies
- Positive Investment Outlook: Cathie Wood holds a $574 million stake in Palantir Technologies, reflecting strong confidence in the company amid rising geopolitical conflicts and military budgets, positioning it as a full-stack AI platform for modern warfare.
- Integrated Technology Advantage: Palantir's Foundry, Gotham, and Apollo systems are tightly integrated, providing a comprehensive solution from data collection to real-time decision-making, making it a one-stop shop for government defense needs and enhancing operational efficiency.
- Enhanced Target Identification: With AI integration, Palantir's target identification capacity has surged from 100 targets per day to 5,000, with future iterations expected to reach 1,000 targets per hour, significantly reducing decision cycles and improving military responsiveness.
- Outstanding Market Performance: Despite being the biggest detractor in GMO's portfolio, Palantir's stock surged 135% over the past year, indicating market recognition of its growth potential, even as its price-to-sales ratio exceeds 100, continuing to attract investor interest.
See More
NHS Grants Palantir Unlimited Access to Patient Data
- Access Permission Change: The UK's National Health Service (NHS) has decided to grant staff from companies including Palantir 'unlimited access' to identifiable patient data to support the development of its flagship data platform, raising significant public concern over data privacy.
- Large Contract Value: Palantir secured a £330 million ($448.4 million) contract in 2023 to develop the National Data Integration Tenant (NDIT) for the NHS, aimed at integrating disparate NHS datasets into a single system to enhance data management efficiency.
- External Access Management: NHS has agreed to create an 'admin' role allowing non-staff unlimited access to the NDIT and identifiable patient data, although an internal briefing note recommends capping external admin access and subjecting such permissions to regular review to ensure data security.
- Public Scrutiny and Review: Palantir's data access has drawn considerable public scrutiny due to its work with U.S. government defense agencies, with the briefing note suggesting that external access should be time-limited and regularly reviewed to address concerns over patient data access.
See More
Palantir Reports Strong Revenue and Profit Growth
- Significant Revenue Growth: Palantir's stock price on the afternoon of May 7, 2026, indicates strong revenue growth, suggesting the company's performance continues to improve, which is expected to further boost investor confidence.
- Profit Increase: The company reports profit growth, reflecting the effectiveness of its business model and strong market demand, which may attract more institutional investors' attention.
- Positive Market Reaction: Following the video release, Palantir's stock price rose by 0.55%, demonstrating investor optimism regarding the company's future development and enhancing its competitiveness in the tech industry.
- Optimistic Strategic Outlook: With simultaneous revenue and profit growth, Palantir is poised to continue expanding its market share in the future, further solidifying its leadership position in the data analytics sector.
See More
Karp Critiques AI Models as Business Threat
- Executive Warning: CEO Alex Karp's criticism of internal 'slop' indicates concerns about operational efficiency, suggesting that the company risks losing its competitive edge if not addressed.
- Investor Concerns: Investors are reacting to Karp's remarks with apprehension, believing that failure to effectively tackle the challenges posed by AI models could impact market share and long-term profitability.
- Employee Anxiety: Some employees express unease about the company's future direction, fearing that the rise of AI models may lead to layoffs or business restructuring, thereby affecting job security.
- Need for Strategic Adjustment: Karp's critique underscores the necessity for the company to make strategic adjustments to navigate the rapidly changing technological landscape, ensuring competitiveness in the AI sector and safeguarding core business operations.
See More
Palantir Reports 85% Revenue Surge in Q1, Raises Guidance
- Significant Revenue Growth: Palantir's Q1 total revenue reached $1.633 billion, marking an 85% year-over-year increase, with U.S. revenue soaring 104% to $1.282 billion, indicating strong performance amid accelerating AI demand.
- Government and Commercial Revenue Surge: U.S. government revenue accounted for $687 million, an 84% increase, while commercial revenue rose 133% to $595 million, demonstrating the company's expanding market penetration across various sectors.
- Upgraded Annual Revenue Guidance: Following the robust Q1 results, Palantir raised its 2023 revenue guidance to between $7.650 billion and $7.662 billion, reflecting the company's confidence in future growth prospects.
- Analyst Price Target Increases: Citi and Rosenblatt both raised their price targets to $225, while Bank of America set a target of $255, indicating a positive market outlook for Palantir's future performance.
See More
Palantir Reports Exceptional Q1 Performance Amidst Growth Concerns
- Accelerating Growth: Palantir's Q1 revenue surged 85% year-over-year, with U.S. commercial growth reaching an impressive 133%, indicating strong demand for its data analytics platform, even as its stock remains 29% below its all-time high.
- High Profit Margins: The company reported an operating margin of 46% in Q1, up from 27% a year ago, showcasing its success in efficient operations and client acquisition, thereby enhancing its competitive position in the market.
- Market Concerns and Valuation Pressure: Despite exceeding Wall Street expectations, Palantir's P/E ratio stands at 75 and its price-to-sales ratio at 70, suggesting that much of the growth is already priced in, which may lead to downward pressure on the stock.
- Future Outlook and Growth Potential: CEO Karp anticipates revenue doubling by 2027, and if the compound annual growth rate reaches 50%, revenue could rise from $5 billion to approximately $40 billion, indicating potential value for patient investors despite necessary price adjustments.
See More
